Concerto Biosciences
About Concerto Biosciences
Concerto Biosciences utilizes the kChip discovery engine to construct and analyze millions of defined microbial communities, identifying the specific microbes and metabolites that drive desired product functions. The company partners with biotech and biopharma firms to develop microbial, prebiotic, and postbiotic products that enhance health outcomes, particularly in conditions like atopic dermatitis.
```xml <problem> Developing effective microbe-based products is challenging due to the complexity of microbial communities and their interactions. Translating lab results into real-world efficacy for skincare, chronic disease, and nutrition applications remains a significant hurdle. </problem> <solution> Concerto Biosciences utilizes its kChip discovery engine to construct and analyze millions of defined microbial communities, identifying specific microbes, nutrients, and metabolites that drive desired product functions. The company's kAI model learns from vast ecological datasets generated by the kChip, mapping interactions and predicting behavior to enable the development of microbial, prebiotic, and postbiotic products. By understanding and harnessing microbial ecology, Concerto aims to create reliable products with real-world efficacy for various applications. They partner with biotech and biopharma firms to develop transformative products that enhance health outcomes. </solution> <features> - kChip discovery engine for constructing and analyzing millions of defined microbial communities simultaneously. - Identification of specific microbes, nutrients, and metabolites that drive desired product functions. - kAI model for mapping interactions and predicting behavior within microbial communities. - Development of microbial, prebiotic, and postbiotic products for skincare, chronic disease, and nutrition applications. - Focus on translating lab results into real-world efficacy. </features> <target_audience> Concerto Biosciences primarily targets biotech and biopharma companies seeking to develop innovative microbial-based products. </target_audience> ```
What does Concerto Biosciences do?
Concerto Biosciences utilizes the kChip discovery engine to construct and analyze millions of defined microbial communities, identifying the specific microbes and metabolites that drive desired product functions. The company partners with biotech and biopharma firms to develop microbial, prebiotic, and postbiotic products that enhance health outcomes, particularly in conditions like atopic dermatitis.
Where is Concerto Biosciences located?
Concerto Biosciences is based in Cambridge, United Kingdom.
When was Concerto Biosciences founded?
Concerto Biosciences was founded in 2020.
How much funding has Concerto Biosciences raised?
Concerto Biosciences has raised 25440000.
- Location
- Cambridge, United Kingdom
- Founded
- 2020
- Funding
- 25440000
- Employees
- 32 employees
- Major Investors
- Springboard Enterprises